Quick Overview: November 29, 2016 Bucksbaum Institute public lecture given by From Discovery to Disclosure: The Wins and Woes of Returning Genetic Research Results. What should BRCA1 and BRCA2 carriers do with this information?

Angela Bradbury Md Rethinking The - Detailed Overview & Context

November 29, 2016 Bucksbaum Institute public lecture given by From Discovery to Disclosure: The Wins and Woes of Returning Genetic Research Results. What should BRCA1 and BRCA2 carriers do with this information? WeRockTech CodeFirstGirls OnesToWatch 2016 (CF: G) For more than 30 years, small cell lung cancer has remained one of the most aggressive and difficult-to-treat cancers - marked by ... This week on PINK365, Miranda sits down with

Cancer Risk Factors, Screening Programs, and early Detection by From recent studies on alcohol consumption to obesity, how do we talk to our patients about cancer risk mitigation? Join the ... Donate to Support Breast Cancer Research at UMSOM: The University of On the 40th Anniversary of Breast Cancer Awareness Month, we reflect on the progress made in the fight against breast cancer. Connie Harrington, now 78, received her initial diagnosis of advanced pancreatic cancer in December 2021 in her home state of ... Anna Marier delivered this talk as part of the CIC Lecture Series at the Douglas Research Centre on April 29, 2026. Anna is a ...

What does the future of metastatic breast cancer (MBC) research look like? Join

Photo Gallery

Angela Bradbury, MD "Rethinking the Traditional Office Visit"
Research Ethics & Policy Series (REPS): Angela R. Bradbury, MD
Advice for BRCA1 and BRCA2 Carriers
WeRockTech CFGOnesToWatch2016 Angela Bradbury
Breast Cancer News and New Research in Controlling Side Effects
Induced Proximity Meets Oncology: A New Era In Cancer Therapy | Dr. Angela Coxon - Amgen
PINK365: Dr. Teplinsky on Risk Reduction, Survivorship & the Future of Women’s Health
A presurgery combination therapy may improve outcomes for women with HER2 positive breast cancer
07a   Cancer Risk Factors, Screening Programs, and early Detection by Dr. Angela HYDE
Ep. 5 - How Patients Can Mitigate Their Cancer Risks in 2025
River of Life Tribute Challenge: Honoring Dr. Angela Brodie
Meet Angela Waanders, MD, MPH, Section Head of the Brain Tumor Program at Lurie Children’s
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored